National Procurement for HIV and Preventative Treatments

A Contract Award Notice
by NHSE&I

Source: Contracts Finder
Type: Framework (Products)
Duration: 1.5 year
Value: £270M

Sector: HEALTH
Published: 08 Mar 2022
Delivery: 01 Feb 2022 to 31 Jul 2023
Deadline: 07 Sep 2021 17:00

Concepts

Location

Geochart for 1 buyers and 15 suppliers

1 buyer

Nhse&I London

15 suppliers

Gilead Sciences London
Merck Sharpe & Dohme London
Janssen Cilag High Wycombe
Amarox Harrow
Tillomed Laboratories Great Marlings
Glenmark Pharmaceuticals Europe Watford
Macleods Pharma Billingham
Viiv Healthcare Brentford
Abbvie Maidenhead
Mylan Hatfield
Mawdsley Brooks Salford
Lupin Healthcare Slough
Teva Castleford
Drreddys Laboratories Beverley
Zentiva Pharma London

Description

Lot 1 - supply of licensed antiretroviral therapy (ART) for the treatment of HIV (Adults and Children) and licensed pre-exposure prophylaxis (PrEP) packs for the prevention of HIV. Lot 2 - a service to supply over labelled post-exposure prophylaxis (PEP) packs for the prevention of HIV.

Award Detail

1	Gilead Sciences (London) Value: £230,000,000
2	Merck Sharpe & Dohme (London) Value: £230,000,000
3	Janssen Cilag (High Wycombe) Value: £230,000,000
4	Amarox (Harrow) Value: £230,000,000
5	Tillomed Laboratories (Great Marlings) Value: £230,000,000
6	Glenmark Pharmaceuticals Europe (Watford) Value: £230,000,000
7	Macleods Pharma (Billingham) Value: £230,000,000
8	Viiv Healthcare (Brentford) Value: £230,000,000
9	Abbvie (Maidenhead) Value: £230,000,000
10	Mylan (Hatfield) Value: £230,000,000
11	Mawdsley Brooks (Salford) Value: £230,000,000
12	Lupin Healthcare (Slough) Value: £230,000,000
13	Teva (Castleford) Value: £230,000,000
14	Drreddys Laboratories (Beverley) Value: £230,000,000
15	Zentiva Pharma (London) Value: £230,000,000